Insights

Individualized drug dosing for preterm infants can be improved using real-time physiological and drug data. A novel computational framework enables personalized medication adjustments for neonatal intensive care.

Area of Science:

  • Neonatal pharmacology
  • Computational biology
  • Intensive care medicine

Background:

  • Neonatal intensive care units (NICUs) utilize numerous drugs for preterm infants.
  • Current drug dosing relies on population pharmacokinetic data, often insufficient for individual needs.
  • Preterm infants require adaptable medication strategies due to physiological immaturity.

Purpose of the Study:

  • To propose a novel computational framework for individualized drug dosing in preterm neonates.
  • To enable real-time adjustment of medication based on infant response.
  • To improve therapeutic outcomes for critically ill newborns.

Main Methods:

  • Development of a computational framework integrating real-time physiological and drug administration data.
  • Application of temporal data analysis for dynamic dosing recommendations.
  • Utilizing cloud computing for widespread accessibility and deployment.

Main Results:

  • The proposed framework facilitates personalized drug dosing by analyzing real-time data.
  • Integration of physiological parameters allows for timely modification of standard dosing.
  • The system aims to optimize drug therapy for individual preterm infants.

Conclusions:

  • A novel computational framework offers a promising approach for individualized drug dosing in preterm infants.
  • Real-time data integration and analysis are key to optimizing neonatal pharmacotherapy.
  • Cloud-based deployment can enhance the accessibility of personalized medicine in NICUs.

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
335
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
402
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
374
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
375
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
366
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
429